Timing of BNT162b2 vaccine prior to COVID‐19 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort study

The COVID‐19 pandemic continues to pose challenges to the treatment of hemato‐oncology patients. Emergence of COVID‐19 variants, availability of vaccine boosters and antiviral treatments could impact their outcome. We retrospectively studied patients with hematologic malignancies and confirmed COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutwein, Odit, Herzog Tzarfati, Katrin, Apel, Arie, Rahimi‐Levene, Naomi, Ilana, Levy, Tadmor, Tamar, Koren‐Michowitz, Maya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660398/
https://www.ncbi.nlm.nih.gov/pubmed/37877352
http://dx.doi.org/10.1002/cam4.6397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660398/
https://www.ncbi.nlm.nih.gov/pubmed/37877352
http://dx.doi.org/10.1002/cam4.6397

Ejemplares similares